MENU
LVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LAVA Therapeutics (LVTX) Ownership - Who owns LAVA Therapeutics?
Profile
Industry
N/A
Address
Yalelaan 62
Phone
+31 850163100
Employees
35
Web
https://www.lavatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.35M
P/E Ratio
N/A
Total Cash
86.8M
Projected Growth
N/A
Total Debt
6.16M
Revenue
7.4M
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
3.30
Total Debt/Equity
N/A
Revenue/Share
0.27 USD as % of share price
Fundamentals
LVTX
Capitalization
27.4M
P/E Ratio
N/A
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
86.8M
Total Cash/Share
3.30
Total Debt
6.16M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.27%
Revenue
7.4M
ROE
N/A
Book Value
42.9M
P/B Ratio
0.83
Cash Flow
N/A
Earnings
-0.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.72M
Current Ratio
6.39
Current Revenue Per Employee
188972.97
Dividends Per Share - Security
N/A
EBITDA
-24.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-22.51
Shares Held By Institutions
6.85M
Shares Outstanding - Current
26.3M
Total Liabilities
49.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-34.177
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Yalelaan 62
Phone
+31 850163100
Employees
35
Web
https://www.lavatherapeutics.com